Kolexia
Jouve Jean-Louis
Gastro-entérologie
Hôpital François Mitterrand
Dijon, France
82 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du foie Tumeurs colorectales Carcinomes Carcinome hépatocellulaire Métastase tumorale Adénocarcinome Tumeurs des voies biliaires Tumeurs du côlon Tumeurs du rectum

Industries

Amgen
2 collaboration(s)
Dernière en 2023
MSD
1 collaboration(s)
Dernière en 2022
Norgine
1 collaboration(s)
Dernière en 2023
AstraZeneca
1 collaboration(s)
Dernière en 2023

Dernières activités

AMPULLOMA: Study of Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   23 mars 2022
SATURNE: A Double-Blind, Randomized, Phase II/III Study Comparing the Use of Chemoembolization Combined With Sunitinib Against Chemoembolization Combined With a Placebo in Patients With Hepatocellular Carcinoma (SATURNE)
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   17 mars 2022
Intra-arterial Hepatic Beads Loaded With Irinotecan With Concomitant Chemotherapy With FOLFOX in Patients With Colorectal Cancer With Unresectable Liver Metastases: a Phase II Multicenter Study
Essai Clinique (Biocompatibles UK Ltd)   21 décembre 2020
Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis: A Preliminary Study.
Journal of clinical gastroenterology   11 août 2020
Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients.
Alimentary pharmacology & therapeutics   11 août 2020
Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study.
Clinics and research in hepatology and gastroenterology   21 juin 2020
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study.
British journal of cancer   08 juin 2020
Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis: Randomized Phase III Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   27 mars 2020
Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer: Multicenter Phase III Randomized Study of FOLFIRI Plus Bevacizumab Following or Not by a Maintenance Therapy With Bevacizumab in Patients With Non-Pretreated Metastatic Colorectal Cancer
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   27 mars 2020
Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study.
Journal of cancer research and clinical oncology   04 juillet 2019